The Transformative Potential of CAR-T Therapies: Need for Deeper Consideration of Ethics & Equity of Access for Patients

By Aisling McMahon, Alanna Kells and Sinéad Masterson   CAR-T therapies (Chimeric Antigen Receptor T-Cell Therapy) have demonstrated remarkable potential for the treatment of certain blood cancers. CAR-T therapy is a cellular immunotherapy which involves the extraction of a sample of a patient’s white blood cells (T-cells) which are then modified outside the body to […]

Read More…